You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 9,717,740

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,717,740 protect, and when does it expire?

Patent 9,717,740 protects ALKINDI SPRINKLE and is included in one NDA.

This patent has twenty-six patent family members in twenty-one countries.

Summary for Patent: 9,717,740

Title:	Treatment of adrenal insufficiency
Abstract:	The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.
Inventor(s):	Huatan; Hiep (Maidstone, GB), Ross; Richard (Sheffield, GB), Whitaker; Martin (Nottingham, GB)
Assignee:	Diurnal Limited (Cardiff, GB)
Application Number:	15/473,724
Patent Claim Types: see list of patent claims	Use; Dosage form;

Drugs Protected by US Patent 9,717,740

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-001	Sep 29, 2020		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Sign Up
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-002	Sep 29, 2020		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Sign Up
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-003	Sep 29, 2020		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Sign Up
Eton	ALKINDI SPRINKLE	hydrocortisone	GRANULE;ORAL	213876-004	Sep 29, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				TREATMENT OF ADRENAL INSUFFICIENCY	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,717,740

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	1119985.8	Nov 19, 2011

International Family Members for US Patent 9,717,740

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2012338583	⤷ Sign Up
Brazil	112014011745	⤷ Sign Up
Canada	2854717	⤷ Sign Up
Cyprus	1123130	⤷ Sign Up
Denmark	2780003	⤷ Sign Up
European Patent Office	2780003	⤷ Sign Up
Spain	2782503	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.